Beijing UNIONLUCK Biological Technology CO.,LTD.

To be the brand enterprise of biological area in “2025 Made In China”

Beijing Unionluck Biological Technology CO.,LTD,the predecessor of Beijing UnionLuck Biotechnology Research and Development Center (hereinafter referred to as the Concorde Locke), founded in 1996, in 2013 to achieve the reorganization transition, is a national high-tech enterprises, the main focus on the field of biotechnology, Focus on early warning, diagnosis, treatment, and other related product development and production systems of cardiovascular and cerebrovascular diseases. The company has a complete basic research, medical transforming scientific and technological achievements, standards of production, quality control, marketing and management system.

Cardiovascular and cerebrovascular diseases have become the biggest ye threat to human health killer, which has a fast onset, the mortality rate is high. on the areas of cardiovascular disease diagnosis and treatment, the focus of "technological innovation, early warning, precision medical, health management." Company R & D center in China Research Institute Hospital, Peking University, clinical research hospital abroad base, independent research and development, while maintaining market share in the field of newborn screening, and actively expand the diagnosis and treatment of cardiovascular diseases market . May 2015, the company and the United States LUMINEX in Beijing signed a protein chip project of cardiovascular and cerebrovascular areas of cooperation agreements, which aims to build cardiovascular and cerebrovascular diseases, the full range of diagnostic testing platform, the different diagnostic markers in combination to achieve a comprehensive and effective diagnosis of cardiovascular diseases.

Meanwhile vascular heart brain in vitro diagnostic field of sustainable development, the compasny and the Peking University and GuizhouTaibang Biological Products Co., Ltd. for cooperation, initiated the development of recombinant human blood drugs, for the treatment of cardiovascular and cerebrovascular diseases. The company is committed to creating covers the diagnosis and treatment of cardio-cerebral specialization both platforms in the field of vascular research and development production and operation, thereby build a cardiovascular disease diagnosis and therapeutic products industry base.

The LUCKYOUYOU is the platform which consisting of education and health service,Covering the fitness、retirement、health maintenance、mentality、public welfare and so on. Through the education to make people realize the importance of Cardiovascular and cerebrovascular health,

Beijing UNIONLUCK uphold national strategic science and technology

 

Innovation, focusing on health management area major health industry, and strive to create a "2025 Made in China" brand biomedical companies.

+86 10 51295656-8080

Address: Building 2,Yard 11,Kechuang 14 road, Beijing Economic-technogical Development Area.

Power By Shangpin